Domestic

Control of HIV after Antiretroviral Medication Pause (CHAMP)

• Principal Investigator(s): Jonathan Li
• Study Contact: Jonathan Li, jli@bwh.harvard.edu
• Description of Subjects: Post-treatment controllers
• Location (Domestic vs. International): United States, Canada
• Enrollment Period: n/a
• Enrollment Goal: 200
• Key Exclusion and Inclusion Criteria: Discontinued...

Read more about Control of HIV after Antiretroviral Medication Pause (CHAMP)

HIV Reservoir Dynamics During Antiretroviral Therapy (The HIV Eradication and Latency [HEAL] Cohort)

• Principal Investigator(s): Athe Tsibris
• Study Contact:, Athe Tsibris, atsibris@bwh.harvard.edu
• ...

Read more about HIV Reservoir Dynamics During Antiretroviral Therapy (The HIV Eradication and Latency [HEAL] Cohort)

Community Health Applied Research Network (CHARN)

• Principal Investigator(s): Kenneth Mayer, MD
• Study Contact: Kenneth Mayer, MD
• Description of Subjects: Patients receiving primary care at participating community health centers across the U.S.
• Location (Domestic vs. International): Boston, MA; greater MA; New England
• Enrollment Period: 2007-2014
• Enrollment Goal: >50,000
• Key Exclusion and...

Read more about Community Health Applied Research Network (CHARN)

Preventive sexual health screening among female-to-male (FTM) transgender adult patients

• Principal Investigator(s): Sari Reisner
• Study Contact: Dana Pardee, 617-927-6371, dpardee@fenwayhealth.org
• Description of Subjects: Female-to-male (FTM) transgender individuals between the ages of 21-64 years who have a cervix and who have been sexually active in the past 36 months
• Location (Domestic vs. International): Fenway Heatlh, Boston, MA
• Enrollment...

Read more about Preventive sexual health screening among female-to-male (FTM) transgender adult patients

ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study, (AMC Protocol #A01)

• Principal Investigator(s): Lori Panther, MD, MPH
• Study Contact: Lori Panther, MD, MPH, 617-927-6056, lpanther@bidmc.harvard.edu
• Description of Subjects: HIV+ men, women and transgender people >35 years old
• Location (Domestic vs. International): University of California at San Francisco; Cornell Medical Center; Montefiore Medical Center/Albert Einstein...

Read more about ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study, (AMC Protocol #A01)

Optimizing PrEP through Shared Decision Making

• Principal Investigator(s): Douglas Krakower
• Study Contact: Douglas Krakower
• Description of Subjects: HIV-uninfected men who have sex with men
• Location (Domestic vs. International): BIDMC, Fenway Health, Greater Boston region (i.e., from community)
• Enrollment Period: 2013 to present
• Enrollment Goal: 100 participants
• Key Exclusion and Inclusion Criteria:...

Read more about Optimizing PrEP through Shared Decision Making

The MATCH Study of HIV and Aging

• Principal Investigator(s): Monty Montano
• Study Contact: Brooke Ferguson Brawley; BBRAWLEY@PARTNERS.ORG; 617-525-9195
• Description of Subjects: Adult males and females, 50-65 years old. If HIV+, on effective ART.
• Location (Domestic vs. International): Boston Metropolitan Area
• Enrollment Period: 2015-2016
• Enrollment Goal:...

Read more about The MATCH Study of HIV and Aging

Fenway Cohort affiliated with (North American- AIDS Cohort Collaboration on Research and Design (NA-ACCORD))

• Principal Investigator(s): Kenneth Mayer, MD
• Study Contact: Chris Grasso, MPH, 617-927-6018, cgrasso@fenwayhealth.org
• Description of Subjects: Fenway Health medical patients who have had at least 2 HIV primary care visits at Fenway in a 12 month period and are 18 years or older
• Location (Domestic vs. International): Fenway has participants from all over the New England geographic...

Read more about Fenway Cohort affiliated with (North American- AIDS Cohort Collaboration on Research and Design (NA-ACCORD))

HIV Research Network (HIVRN)

• Principal Investigator(s): Ken Mayer
• Study Contact: Ken Mayer, DrPH, 617 927 6087, kmayer@fenwayhealth.org
• Description of Subjects: HIV-infected patients aged 18 and older receiving medical care at Fenway Health. (HIVRN includes pediatric data, but Fenway Health only submits adult patient data)
  • HIV+
  • HIV/HCV Co-infected
...

Read more about HIV Research Network (HIVRN)

Pediatric HIV/AIDS Cohort Study (PHACS - multicenter 22 sites)

• Principal Investigator(s): George R. Seage III, DSC., MPH
• Study Contact: Liz Salomon, EdM, Program Director, 617-432-6762, lsalomon@hsph@harvard.edu
• Description of Subjects: HIV perinatally infected and exposed children/adolescents/young adults and their caregivers/ birthmoms enrolled and followed at 22 US sites.
• Location (Domestic vs. International):...

Read more about Pediatric HIV/AIDS Cohort Study (PHACS - multicenter 22 sites)

CFAR Network of Integrated Clinical Systems (C-NICS)

• Principal Investigator(s): Ken Mayer, MD
• Study Contact:, Ken Mayer, Tel: 617-927-6087, kmayer@fenwayhealth.org
• Description of Subjects: 30,000 PLHIV in care at 8 HIV primary care centers
• Location (Domestic vs. International): Fenway Health; UNC; UAB; Case Wester; UCSD; UCSF; U Wash
• Enrollment Period: 2005-ongoing
• Enrollment Goal: open cohort, >30,000 PLHIV.
• ...

Read more about CFAR Network of Integrated Clinical Systems (C-NICS)

Effect on CNS with ART switch off EFV-based therapy

• Principal Investigator(s): Nina Lin
• Study Contact:  Nina Lin, nhlin@bu.edu
• Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
• Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
• Enrollment Period: Beginning January 2014
• Enrollment Goal:...

Read more about Effect on CNS with ART switch off EFV-based therapy

HIV and Aging Cohort Study

• Principal Investigator(s): Nina Lin
• Study Contact:  Nina Lin, nhlin@bu.edu
• Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
• Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
• Enrollment Period: 2011-present
• Enrollment Goal: 
• Key Exclusion and...

Read more about HIV and Aging Cohort Study

Pediatric HIV/AIDS Cohort Study (PHACS -BCH site only)

• Principal Investigator(s): Sandra Burchett (site leader), George Seage PI
• Study Contact: Sandra Burchett, MD, Tel. 617 355-6832, sandra.burchett@childrens.harvard.edu
• Description of Subjects: AMP:450 HIV+ youth, 150 HIV-controls; SMARRT: >1700 HIV neg/ARV exposed infants,youth. Study domains: cardiopulm, metabol, complications and HIV disease, maternal exposures, neuro, oral health, adolescent
• ...

Read more about Pediatric HIV/AIDS Cohort Study (PHACS -BCH site only)

Phenogenetic HIV Negative

• Principal Investigator(s): Philip De Jager
• Study Contact: Laura Glick, 617-264-5947; lglick@partners.org   or   Tina Xue, txue@partners.org
• Description of Subjects: Self reported healthy, 18+, recallable for blood draw based on phenotype and genotype
• Location (Domestic vs. International): Domestic
• Enrollment Period: 2006 - ongoing...

Read more about Phenogenetic HIV Negative

Pages

• 1
• 2
• »
• last